Fresh Meadows, New York Clinical Trials

A listing of Fresh Meadows, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 414 clinical trials
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

cancer metastatic
targeted therapy
estrogen
endocrine therapy
cancer
Investigational Site Number 8400009
 (1.5 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +125 other locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

tremor
parkinsonism
bradykinesia
dopamine
dopamine transporter
Neuroscience Institute at Great Neck
 (4.8 away)
  • 0 views
  • 28 Jun, 2022
  • +125 other locations
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

This is a Phase III, two-arm, randomized, double-blind placebo-controlled study in participants with HER2-positive primary breast cancer who have received preoperative chemotherapy and HER2-directed therapy, including trastuzumab followed by surgery, with a finding of residual invasive disease in the breast and/or axillary lymph nodes.

Mount Sinai Medical Center
 (8.7 away) Contact site
  • 0 views
  • 05 Oct, 2021
  • +301 other locations
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II) (INTRAGO-II)

INTRAGO II resembles a multicentric, prospective, randomized, 2-arm, open-label clinical phase III trial which tests if the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of intraoperative radiotherapy (IORT) to standard radiochemotherapy.

Long Island Jewish Medical Center, North Shore University Hospital
 (5.3 away) Contact site
  • 0 views
  • 20 Jul, 2022
  • +16 other locations
Test_question

test

Accepts healthy volunteers
SiteQ7
 (4.6 away) Contact site
  • 0 views
  • 14 Dec, 2022
  • 1 location
AutoRun014775  

AutomationRun014775

AutoSite014775
 (8.7 away)
  • 0 views
  • 22 Dec, 2022
  • +1 other locations
AutoRun0147831

AutomationRun0147831

AutoSite0147831
 (8.7 away) Contact site
  • 0 views
  • 10 Jan, 2023
  • 1 location
AutoRun0147832

AutomationRun0147832

AutoSite0147832
 (8.7 away) Contact site
  • 0 views
  • 19 Jan, 2023
  • 1 location
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue. The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure. This clinical trial aims to assess the …

Accepts healthy volunteers
Site 001
 (4.6 away) Contact site
  • 0 views
  • 25 Jul, 2023
  • +21 other locations
Automation_Study_42392  

Overview_42392

AutoSite12082
 (7.3 away)
  • 0 views
  • 31 Jan, 2024
  • 1 location